v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
Cash Flows From Operating Activities:              
Net loss $ (33,836,197) $ (10,299,566) $ (11,495,947) $ (11,694,569) $ (53,416,735) $ (36,591,022)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation expense         4,307,286 3,750,923  
Accretion of financing costs         307,428 2,790,566  
Amortization of right-of-use asset         91,911 82,952  
Write-down of inventory to net realizable value         697,544 2,869,221  
Stock-based compensation 27,612,308   3,322,575   33,143,776 12,824,605  
Change in fair value of derivative liability         (705,184)  
Change in fair value of conversion option         (138,060)  
Change in fair value of liability-classified equity-linked contracts         (737,040)  
Loss on debt extinguishment     675,648  
Loss on private placement     567,161  
Changes in operating assets and liabilities:              
Accounts receivable         (4,975,379) (818,628)  
Inventory         (1,136,000) (2,967,846)  
Grants receivable         244,238 26,106  
Prepaid expenses and other         327,997 3,449  
Accounts payable and accrued liabilities         876,467 (4,643,041)  
Operating lease liability         (85,437) (89,161)  
Net Cash Used in Operating Activities (2,700,000)       (19,616,904) (23,099,351) $ (28,900,000)
Cash Flows From Investing Activities:              
Purchase of mining properties         (1,317,739)  
Acquisition of property and equipment         (8,408,412) (2,000,713)  
Net Cash Used in Investing Activities         (9,726,151) (2,000,713)  
Cash Flows From Financing Activities:              
Proceeds from issuance of common shares through At-The-Market offering         45,513,181 7,579,122  
Payment of issuance costs of common shares through At-The-Market Offering         (354,269)  
Proceeds from employee stock purchase plan         211,846 140,746  
Proceeds from subscription agreements         1,900,000  
Proceeds from registered direct offerings         15,000,000  
Payment of issuance costs, registered direct offerings         (1,089,000)  
Proceeds from exercise of share purchase warrants         9,983,020  
Proceeds from notes payable, net of issuance costs         9,900,000  
Principal paid on notes payable         (7,483,333)  
Net Cash Provided by Financing Activities         55,353,778 25,947,535  
Increase in Cash and Restricted Cash         26,010,723 847,471  
Cash and Restricted Cash - Beginning of Period   $ 12,474,304   $ 7,001,786 12,474,304 7,001,786 7,001,786
Cash and Restricted Cash - End of Period $ 38,485,027   $ 7,849,257   $ 38,485,027 $ 7,849,257 $ 12,474,304